Americans Demand Stricter Rules as Toxic Substances Spark National Anxiety

A clear divide has emerged between public concerns over chemical safety and the Trump administration's approach to regulation. While most Americans demand stricter oversight, the government has instead moved to boost production of controversial chemicals like glyphosate. Surveys reveal widespread anxiety about exposure to toxic substances in everyday products, food, and water.

Between 70% and 90% of American adults express serious worries about harmful substances in their daily lives. These concerns span age groups and political affiliations, with strong majorities calling for more action. Over 80% of those surveyed believe companies cannot be trusted to ensure safety without government intervention.

The substances causing the most alarm include bisphenol A (BPA), phthalates, and perfluoroalkyl substances (PFAS), all linked to health risks. Flame retardants, heavy metals, pesticides, and endocrine disruptors also feature prominently in public fears. More than 60% of adults are particularly troubled by substances in children's toys, baby products, food packaging, and personal care items.

Despite these concerns, the Trump administration took a different path in 2020. Instead of tightening regulations, it invoked the Defense Production Act to increase domestic glyphosate production—a substance classified as a probable carcinogen. The move supported Bayer/Monsanto, which faced ongoing legal challenges over glyphosate's safety. No new restrictions on the substance were introduced that year.

Public demand for accountability remains high. Around 77% of respondents insist that industry, not taxpayers, should cover the costs of cleaning up substance pollution. Meanwhile, 84% believe the federal government must do more to identify and regulate dangerous substances in consumer products.

The gap between public opinion and policy action leaves many Americans uneasy. With broad agreement on the need for stronger safeguards, calls for government and industry to address substance risks continue to grow. The push for stricter regulation and corporate responsibility shows no signs of fading.